David Tuller (University of California, Berkeley), Steven Lubet (Northwestern University), and I have written an opinion piece over at Health Affairs. It’s on the implications of recent developments in ME and chronic fatigue syndrome for the treatment of Long COVID. We argue that the paradigm shift signalled by the UK’s […]
Last October, I wrote that COVID-19 had created a stampede of shoddy research. Little has changed in the interim. Putting all hands to the pump might feel appropriate in a crisis, but during a global public health emergency, rushing headlong into the scholarly frontline is anything but okay. Frankly, it is […]
As you read here in February, David Tuller and I attempted to respond to an alarming research paper that appeared in a recent issue of the Journal of the Royal Society of Medicine. The paper they had published had purported to show evidence that cognitive behavioural therapy leads to symptom improvements in […]
Steven Lubet, a law professor at Northwestern University, has written a powerful piece over at Social Science Space, responding to the awful Op-Ed on Long COVID that appeared the other week in the Wall Street Journal. He doesn’t hold back: It would be mistaken to suppose that disdain for patients […]
Swiss Re Group, “one of the world’s leading providers of reinsurance and insurance,” recently hosted a virtual Expert Forum on “secondary” impacts of COVID. As would be expected, the insurance industry is especially interested in the financial implications of this new disease. The programme covered many of the biophysical sequelae […]
Here is a video of a lecture I gave in Belfast just before COVID, entitled “Off the PACE and not NICE: Challenges with Evidence in ME/CFS.” The lecture was part of a conference organised by Hope 4 ME & Fibro NI (kudos to Joan McParland and team). It hasn’t been […]
